Literature DB >> 10924055

Interleukin-1beta, Src- and non-Src tyrosine kinases, and nitric oxide synthase induction in rat aorta in vitro.

Y Gui1, X L Zheng, M D Hollenberg.   

Abstract

We studied the potential roles for endogenous interleukin-1beta (IL-1beta) and for several signaling pathways in the spontaneous induction in vitro of inducible nitric oxide synthase (iNOS) in endothelium-denuded rat aorta rings. Added IL-1beta augmented, whereas the IL-1beta receptor antagonist IL-1ra blocked, spontaneous iNOS induction. Furthermore, increases in IL-1beta mRNA preceded those of iNOS mRNA. Mitogen-activated protein kinase kinase and phosphatidyl inositol 3' kinase inhibition did not block iNOS induction, whereas nuclear factor kappaB inhibition did. The sarcoma virus tyrosine kinase (Src) family-selective inhibitor 4-amino-5(4-methylphenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP1) blocked the upregulation of IL-1beta mRNA and the subsequent induction of iNOS but not the induction of iNOS stimulated by exogenously added IL-1beta. In contrast, the non-Src inhibitors TP 47/AG 213 and genistein and the tyrosine phosphatase inhibitor vanadate did not affect the spontaneous upregulation of IL-1beta mRNA but blocked both the IL-1beta-mediated and spontaneous induction of iNOS. We conclude that 1) the upregulation of tissue IL-1beta, via a signaling pathway involving a Src family kinase, plays a key role in rat vascular iNOS induction and 2) non-Src tyrosine kinases play roles downstream from IL-1beta for iNOS induction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10924055     DOI: 10.1152/ajpheart.2000.279.2.H566

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  3 in total

1.  Matrix metalloproteinases contribute to endotoxin and interleukin-1beta induced vascular dysfunction.

Authors:  M M Lalu; J Cena; R Chowdhury; A Lam; R Schulz
Journal:  Br J Pharmacol       Date:  2006-07-31       Impact factor: 8.739

2.  P2X7 receptor activation amplifies lipopolysaccharide-induced vascular hyporeactivity via interleukin-1 beta release.

Authors:  Chin-Wei Chiao; Rita C Tostes; R Clinton Webb
Journal:  J Pharmacol Exp Ther       Date:  2008-06-16       Impact factor: 4.030

3.  Interleukin 1-beta (IL-1beta) enhances contractile responses in endothelium-denuded aorta from hypertensive, but not normotensive, rats.

Authors:  Anne M Dorrance
Journal:  Vascul Pharmacol       Date:  2007-06-13       Impact factor: 5.773

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.